![The most frequent cardiovascular manifestations of AS are aortic insufficiency and conduction disorders.[2] Up to 20% of patients with AS have conduction disorders, of which atrioventricular block is the most common.[5,6] Compared with the general population, patients with AS have a 30% to 50% increase in the risk of acute coronary syndromes, deep venous thromboembolism, pulmonary embolism, or stroke.[8] They also have a 25% to 60% greater risk of ischemic heart disease, congestive heart failure, and valvular heart disease.[9] Heart failure may occur secondary to mitral insufficiency.[2] Aortic dissection, which is a rare but frequently fatal complication of aortic insufficiency, has also been observed in patients with AS.[2] Other potential cardiovascular complications include left ventricular diastolic dysfunction, pericarditis, myocardial disease, peripheral vascular disease, and hypertension.[2,3,5]](https://owqo93fpiuc4633lp1zthz57-wpengine.netdna-ssl.com/wp-content/uploads/sites/11/2020/08/thinkstockphotos474641458101_1032729-544x306.jpg)
A reduced dose of prasugrel compared with the standard dose of ticagrelor was associated with maintained anti-ischemic efficacy and safety in elderly or low-weight patients with acute coronary syndrome.
A 75-year-old man with 10-pack-year smoking history, hypertension, and mild chronic obstructive pulmonary disease presents to your office concerned because several of his friends have recently passed away from “heart attacks.” He states that he quit smoking approximately 7 years ago. His physical exam is within normal limits. He has no history of prior cardiac…
Greater scrutiny is needed in evaluating high sensitivity cardiac troponin I levels for the purpose of excluding or diagnosing acute myocardial infarction.
Patients hospitalized with acute coronary syndrome or acute decompensated heart failure who are prescribed opioid medication at discharge may be less likely to resort to planned healthcare use.
Alirocumab significantly decreased severe cardiovascular risks in patients with acute coronary syndrome.
Low-risk acute coronary syndrome patients may require fewer referrals for invasive coronary angiography if they had initial noninvasive testing such as stress echocardiography or cardiovascular magnetic resonance.
Same-day discharge after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes was not predictive of 30-day readmission, death, or bleeding.
The use of a decision aid in patients at risk of acute coronary syndrome increased patient knowledge about their risk.
Only 5.5% of ER patients are diagnosed with 1 of 6 life threatening conditions.
The HEART pathway app provides doctors in the ED with a digital application an already proven method of assessment.
